In breast cancer, an miR-941 inhibitor significantly decreased the proliferation and migration of MDA-MB-231 cells by altering the expression of onco-proteins, including p21, cyclin D1, PP2B-B1, and MMP-13 (99). Here, MMP13 is linked to breast cancer.